Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Deep vs. Moderate Neuromuscular Blockade in Spinal Surgery
NCT05294926Phase 1Unknown
- Sponsor
- Assiut University
- Start
- Apr 2022
- Primary completion
- Jan 2023
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, double-blind trial of rocuronium (2 arms), sponsored by Assiut University. Primary endpoint: Volume of surgical bleeding. Status: unknown.
02
Drugs
rocuronium
Beyond the preview
Go deeper on NCT05294926.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05294926.